Jenburkt Pharmaceuticals Ltd Board of Directors
Board of Directors at Jenburkt Pharmaceuticals Ltd
Ashish Shah
Company Sec. & Compli. Officer
Ashish Bhuta
Chairman & Managing Director
Dilip Bhuta
Whole Time Director & CFO
Hina Mehta
Non-Exec. & Independent Dir.
KRISHNAN SUBHARAMAN
Independent Director
Key Highlights
- Ashish U Bhuta joins the board as Chairman / Executive Director / M D / Promoter, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Dilip H Bhuta joins the board as Executive Director / Whole Time Director / CFO, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Hina Ravindra Mehta joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Sumit A. Thakkar joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- KRISHNAN SUBHARAMAN joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Jenburkt Pharmaceuticals Ltd
NSE: JENBURKTPHARMA
Share Price
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 05 Oct 2026 | 900 |
| 01 Oct 2026 | 925.4 |
| 30 Sep 2026 | 917.65 |
| 29 Sep 2026 | 939.15 |
| 28 Sep 2026 | 938 |
| 25 Sep 2026 | 948.4 |
| 24 Sep 2026 | 956.8 |
| 23 Sep 2026 | 958.3 |
| 22 Sep 2026 | 956.1 |
| 21 Sep 2026 | 987.1 |
Company Fundamentals for Jenburkt Pharmaceuticals Ltd
Market Cap
397 Cr
EPS
81.0
P/E Ratio (TTM)
11.1
P/B Ratio (TTM)
2.0
Day’s High
915.0
Day’s Low
895.5
DTE
0.0
ROE
17.6
52 Week High
1321.0
52 Week Low
892.0
ROCE
23.2
Market Price of Jenburkt Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Jenburkt Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Jenburkt Pharmaceuticals Ltd News Hub
Jenburkt Pharmaceuticals to announce Quarterly Result
Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November
Read more
29 Oct 24
Jenburkt Pharmaceuticals standalone net profit rises 31.15% in the September 2024 quarter
Net profit of Jenburkt Pharmaceuticals rose 31.15% to Rs 9.60 crore in the quarter ended September 2
Read more
05 Nov 24
Jenburkt Pharmaceuticals to hold AGM
Jenburkt Pharmaceuticals announced that the 40th Annual General Meeting(AGM) of the company will be
Read more
21 May 25
Jenburkt Pharmaceuticals to table results
Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 January
Read more
21 Jan 25
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
FAQs for Board of Directors of Jenburkt Pharmaceuticals Ltd
How are members of Jenburkt Pharmaceuticals Ltd Board of Directors selected?
Members of the Jenburkt Pharmaceuticals Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Jenburkt Pharmaceuticals Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Jenburkt Pharmaceuticals Ltd Board of Directors?
Shareholders can interact with the Jenburkt Pharmaceuticals Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Jenburkt Pharmaceuticals Ltd Board of Directors meet?
The Jenburkt Pharmaceuticals Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Jenburkt Pharmaceuticals Ltd Board of Directors?
The Jenburkt Pharmaceuticals Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Jenburkt Pharmaceuticals Ltd?
The current Board of Directors at Jenburkt Pharmaceuticals Ltd includes Ashish U Bhuta( Chairman / Executive Director / M D / Promoter) ,Dilip H Bhuta( Executive Director / Whole Time Director / CFO) ,Hina Ravindra Mehta( Independent Non Exe. Director) ,Sumit A. Thakkar( Independent Non Exe. Director) ,KRISHNAN SUBHARAMAN( Independent Non Exe. Director) . The full list can be found on Jenburkt Pharmaceuticals Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
